The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Guanylyl cyclase C (GCC) expression in lymph nodes (LNs) as a determinant of recurrence in stage II colon cancer (CC) patients (pts).
Daniel J. Sargent
Research Funding - DiagnoCure
Qian Shi
Research Funding - DiagnoCure
Sharlene Gill
Research Funding - DiagnoCure
Christophe Louvet
Research Funding - DiagnoCure
Richard Bernard Everson
Research Funding - DiagnoCure
Udo Kellner
Research Funding - DiagnoCure
Thomas E. Clancy
Research Funding - DiagnoCure
J. Marc Pipas
Research Funding - DiagnoCure
Murray B. Resnick
Research Funding - DiagnoCure
Michael O. Meyers
Research Funding - DiagnoCure
David Huntsman
Research Funding - DiagnoCure
Pierre Validire
Research Funding - DiagnoCure
Umar Farooq
Research Funding - DiagnoCure
Emily S Pavey
No relevant relationships to disclose
Jean-Francois Haince
Employment or Leadership Position - DiagnoCure
Stock Ownership - DiagnoCure
Guillaume Beaudry
Employment or Leadership Position - DiagnoCure
Stock Ownership - DiagnoCure
Yves Fradet
Employment or Leadership Position - DiagnoCure
Stock Ownership - DiagnoCure